PGHH Approves FY26 Audited Results, Recommends ₹60 Dividend
Procter & Gamble Hygiene and Health Care Limited approved audited financial results for FY26. The company recommended a dividend of ₹60 per equity share, payable by September 18, 2026. For FY26, profit after tax was ₹85,650 Lakhs and basic EPS was ₹263.86.
The announcement of audited financial results and a dividend recommendation is a significant event for shareholders, impacting investment decisions and company valuation.
The company reported positive financial results and recommended a dividend, indicating financial health and shareholder returns.
Procter & Gamble Hygiene and Health Care Limited announced the approval of its Audited Financial Results for the Financial Year ended March 31, 2026, during a Board of Directors meeting held on May 28, 2026. The meeting commenced at 12:43 pm and concluded at 13:34 pm. The company also announced that the Board has recommended a dividend of ₹60 per Equity Share for the Financial Year ended March 31, 2026. This dividend, subject to shareholder approval at the upcoming 62nd Annual General Meeting, is scheduled to be paid on or before September 18, 2026.
The company reported total income of ₹95,379 Lakhs for the three months ended March 31, 2026, and ₹4,33,289 Lakhs for the full financial year ended March 31, 2026. Profit before tax for the same periods stood at ₹21,811 Lakhs and ₹1,16,663 Lakhs, respectively. Profit for the period (after tax) was ₹15,313 Lakhs for the quarter and ₹85,650 Lakhs for the year.
Basic Earnings Per Share (EPS) for the financial year ended March 31, 2026, was ₹263.86. The audited financial results were accompanied by an Auditor's Report from Kalyaniwalla & Mistry LLP, which expressed an unmodified opinion.
What to do with a filing like this
Procter & Gamble Hygiene and Health Care Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Procter & Gamble Hygiene and Health Care Limited. Read the original for the full detail.